neuraxon

subsidiary of the international pharmaceutical group, Ferrer Grupo., Double Wood Supplements, NeurAxon Inc., Somazina by Grupo Ferrer Internacional in South Africa, Wellona Pharma Private Limited, Intas Biopharmaceuticals Ltd in India.

Finally, the myelin sheath, neuraxon, and Schwann cell nerve microstructures were observed under an electron microscope (JEOL Ltd., Tokyo, Japan).

NeurAxon, a Canadian company, has developed a first-in-class selective inhibitor of the neuronal form of NOS, which modulates the central and peripheral response to pain and neuronal sensitization.

Another prominent Canadian biotechnology, NeurAxon, received $32 million in financing in 2007 from OrbiMed and Delphi Ventures, both US-based firms, but without Canadian funds as lead lenders.

Meanwhile, Ferrer Therapeutics has taken a different approach with its NeurAxon brain formula, basing the product on citicoline, a substance that the body produces naturally and one that constitutes approximately 30% of the gray matter in the human brain.

12 January 2010 - Pain therapeutics maker NeurAxon Inc said yesterday it has been awarded a USD267,000 (EUR184,137) grant from The Michael J.

-- Ferrer Therapeutics Inc.'s NeurAxon, a pharmaceutical-grade dietary supplement for brain function, is being introduced across the mass market after completing an exclusivity period at CVS/pharmacy.

To attract these consumers, Ferrer Therapeutics markets a pharmaceutical-grade dietary supplement called NeurAxon that contains a neurotransmitter precursor (Citicoline) that Simpson says is important for normal brain function.